Ephraim Philip Lansky, MD (University of Pennsylvania), PhD (Leiden University), MBA (University of Bradford), BA (New College, Sarasota, Florida), is the author or coauthor of 28 peer-reviewed publications, five patents, and two books (Pomegranate: The Most Medicinal Fruit, Basic Books, New York; and Figs: the Genus Ficus, CRC Press, Boca Raton, FL). He is also the founder of Rimonest Limited and Punisyn Pharmaceuticals Limited, companies devoted to the economic development of the pomegranate fruit for nutraceutical, cosmeceutical, and medical applications, respectively. He has 30 years of clinical experience in acupuncture, herbology, homeopathy, and hypnosis. He directs the Laboratory of Applied Metabolomics and Pharmacognosy (LAMP) within the Institute of Evolution, University of Haifa, Israel, and maintains an international consulting practice in complementary medicine and pharmacognosy.
Shifra Lansky holds a BSc in chemistry from Hebrew University in Jerusalem, Israel, where she is presently pursuing her graduate studies. Her focus is on characterizing the three-dimensional structures of naturally occurring proteins. Shifra enjoys playing the violin, painting, and skiing in her spare time.
Helena Paavilainen is a researcher at the Hadassah Medical School, Hebrew University of Jerusalem, Israel. Her main research interests are ethnomedicine, historical ethnopharmacology, and the history of pharmacology, especially the Hebrew, Arabic, and Latin traditions. She wrote her PhD thesis (published as "Medieval Pharmacotherapy: Continuity and Change; Case Studies from Ibn Sina and Some of His Late Medieval Commentators," Leiden: Brill 2009) on the development of medical drug therapy in medieval times and on the potential validity of medieval herbal treatments. She also coauthored with Dr. Lansky the monograph Figs: The Genus Ficus (Boca Raton, FL
